Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's diseaseROSES, A. D.Annals of neurology. 1995, Vol 38, Num 1, pp 6-14, issn 0364-5134Article

On the metabolism of apolipoprotein E and the Alzheimer diseasesROSES, A. D.Experimental neurology (Print). 1995, Vol 132, Num 2, pp 149-156, issn 0014-4886Article

Pharmacogenetics and future drug development and deliveryROSES, A. D.Lancet (British edition). 2000, Vol 355, Num 9212, pp 1358-1361, issn 0140-6736Article

Hereditary components in the neurodegerative diseases : Alzheimer's disease and myotonic dystrophyROSES, A. D.Neurobiology of aging. 1994, Vol 15, Num 2, pp 243-245, issn 0197-4580Conference Paper

Mutants in duchenne muscular dystrophy: implications for preventionROSES, A. D.Archives of neurology (Chicago). 1988, Vol 45, Num 1, pp 84-85, issn 0003-9942Article

Alzheimer diseases : A model of gene mutations and susceptibility polymorphisms for complex psychiatric diseasesROSES, A. D.American journal of medical genetics. 1998, Vol 81, Num 1, pp 49-57, issn 0148-7299Article

Genetic testing for Alzheimer disease : Practical and ethical issues : The aging brain : Limitations in our knowledge and future approacheROSES, A. D.Archives of neurology (Chicago). 1997, Vol 54, Num 10, pp 1226-1229, issn 0003-9942Article

Apolipoprotein E alleles as risk factors in Alzheimer's diseaseROSES, A. D.Annual review of medicine. 1996, Vol 47, pp 387-400, issn 0066-4219Article

Apolipoprotein E affects the rate of Alzheimer disease expression : β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of diseaseROSES, A. D.Journal of neuropathology and experimental neurology. 1994, Vol 53, Num 5, pp 429-437, issn 0022-3069Article

Myotonic muscular dystrophy: from clinical description to molecular geneticsROSES, A. D.Archives of internal medicine (1960). 1985, Vol 145, Num 8, pp 1487-1492, issn 0003-9926Article

Apolipoprotein E is a genetic locus that affects the rate of Alzheimer disease expressionROSES, A. D.Neuropsychopharmacology (New York, NY). 1994, Vol 10, Num 3S, pp 5S-7S, issn 0893-133X, 1Conference Paper

Expression of α-3, α-5, and β-4 neuronal acetylcholine receptor subunit transcripts in normal and myasthenia gravis thymus : identification of thymocytes expressing the α-3 transcriptsMIHOVILOVIC, M; ROSES, A. D.The Journal of immunology (1950). 1993, Vol 151, Num 11, pp 6517-6524, issn 0022-1767Article

Expression of mRNAs in human thymus coding for the α3 subunit of a neuronal acetylcholine receptorMIHOVILOVIC, M; ROSES, A. D.Experimental neurology (Print). 1991, Vol 111, Num 2, pp 175-180, issn 0014-4886Article

Apolipoprotein E and the CNS response to injuryLASKOWITZ, D. T; HORSBURGH, K; ROSES, A. D et al.Journal of cerebral blood flow and metabolism. 1998, Vol 18, Num 5, pp 465-471, issn 0271-678XArticle

Apolipoprotein E and Alzheimer's diseaseSTRITTMATTER, W. J; ROSES, A. D.Annual review of neuroscience. 1996, Vol 19, pp 53-77, issn 0147-006XArticle

A dinucleotide repeat polymorphism in the human Na⁺,K⁺ ATPase, alpha subunit (ATP1A3) geneKAZANTSEV, A; YAMAOKA, L. H; ROSES, A. D et al.Nucleic acids research. 1992, Vol 20, Num 5, issn 0305-1048, p. 1164Article

Gel chromatography on a sepharose 4B column: earlier elution of protein-sodium dodecyl sulfate complexes of low stokes radiiWONG, P; BARBEAU, A; ROSES, A. D et al.Analytical biochemistry. 1985, Vol 146, Num 1, pp 191-198, issn 0003-2697Article

The molecular genetic revolution: its impact on clinical neurologyPAYNE, C. S; ROSES, A. D.Archives of neurology (Chicago). 1988, Vol 45, Num 12, pp 1366-1376, issn 0003-9942Article

Apolipoprotein E uptake and degradation via chloroquine-sensitive pathway in cultivated monkey cells overexpressing low density lipoprotein receptorJENSEN, T. G; ROSES, A. D; JØRGENSEN, A. L et al.Neuroscience letters. 1994, Vol 180, Num 2, pp 193-196, issn 0304-3940Article

Genetic testing and Alzheimer disease : The promiseROSES, A. D.Alzheimer disease and associated disorders. 1998, Vol 12, pp S3-S9, issn 0893-0341, SUP3Article

Reversal of presynaptic deficits of apolipoprotein e-deficient mice in human apolipoprotein E transgenic miceCHAPMAN, S; SABO, T; ROSES, A. D et al.Neuroscience. 2000, Vol 97, Num 3, pp 419-424, issn 0306-4522Article

Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic factor (BDNF)PRÖSCHEL, M; SAUNDERS, A; ROSES, A. D et al.Human molecular genetics (Print). 1992, Vol 1, Num 5, issn 0964-6906, p. 353Article

Cognitive function and apolipoprotein E in very old adults : Findings from the Nun studyRILEY, K. P; SNOWDON, D. A; SAUNDERS, A. M et al.The Journals of gerontology. Series B, Psychological sciences and social sciences. 2000, Vol 55, Num 2, pp S69-S75, issn 1079-5014Article

Neuropathological features of frontotemporal dementia and parkinsonism linked to chromosome 17q21-22 (FTDP-17) : Duke Family 1684HULETTE, C. M; PERICAK-VANCE, M. A; ROSES, A. D et al.Journal of neuropathology and experimental neurology. 1999, Vol 58, Num 8, pp 859-866, issn 0022-3069Article

Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic miceHUAXIN SHENG; LASKOWITZ, D. T; BENNETT, E et al.Journal of cerebral blood flow and metabolism. 1998, Vol 18, Num 4, pp 361-366, issn 0271-678XArticle